{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:25:41Z","timestamp":1791307541227,"version":"4.3.1"},"reference-count":53,"publisher":"Wiley","issue":"S5","license":[{"start":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:00:00Z","timestamp":1433635200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Meda Pharma GmbH & Co. KG"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acne is a chronic disease of the pilosebaceous unit which is most common during adolescence. Four factors are believed to play a key role in the development of acne lesions: excess sebum production, disturbed keratinization within the follicle, colonization of the pilosebaceous duct by <jats:italic>Propionibacterium acnes,<\/jats:italic> and the release of inflammatory mediators into the skin. Consequently, in order to effectively and rapidly reduce acne lesions, treatments need to address as many of these underlying factors as possible. Currently, about half of patients have poor adherence to acne treatments. To overcome this limitation, treatments need to be developed which are well tolerated by patients, and easy for them to use, handle and apply. Topical monotherapies for acne such as retinoids and antimicrobials by themselves have a restricted range of actions against the pathogenic factors of acne. Instead, the Global Alliance to Improve Outcomes in Acne Group recommends combination therapy with a topical retinoid and an antimicrobial agent as the preferred approach for almost all acne patients. The principal advantage of such combinations is that they target more of the underlying pathogenic factors of acne than individual monotherapies and this results in faster and more complete clearing of acne lesions. Fixed\u2010dose combinations are also more convenient than applying two medications separately, which leads to improved adherence with the regimen. By normalizing desquamation, the retinoid component of these combinations allows entry of the antimicrobial agent into the pilosebaceous unit resulting in faster clearance of <jats:italic>P.\u00a0acnes<\/jats:italic>. In conclusion, topical retinoid\/antimicrobial fixed\u2010dose combinations represent a rational approach for the treatment of acne. They should be considered as the cornerstone of acne management and should be used much more in the future.<\/jats:p>","DOI":"10.1111\/jdv.13186","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T01:34:56Z","timestamp":1433986496000},"page":"1-7","source":"Crossref","is-referenced-by-count":81,"title":["From new findings in acne pathogenesis to new approaches in treatment"],"prefix":"10.1111","volume":"29","author":[{"given":"H. P. M.","family":"Gollnick","sequence":"first","affiliation":[{"name":"Department of Dermatology &amp; Venereology Otto\u2010von\u2010Guericke University Magdeburg Magdeburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60321-8"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809050-00001"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6682.1217"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12160"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.045"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.019"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2022"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1991.tb03122.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12616181"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.11.017"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.4.0404"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04374.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03531.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12224"},{"key":"e_1_2_8_17_1","first-page":"20","article-title":"The expression of Toll\u2010like receptors in dermatological diseases and the therapeutic effect of current and newer topical Toll\u2010like receptor modulators","volume":"3","author":"Valins W","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1535"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.334"},{"key":"e_1_2_8_20_1","first-page":"4","article-title":"Physiopathology of acne vulgaris: recent data, new understanding of the treatments","volume":"14","author":"Pawin H","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06933.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12329907"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10897.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm408"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.05.013"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012277"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00667.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07047.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04416.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.02.009"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02190.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01154-X"},{"key":"e_1_2_8_33_1","first-page":"22","article-title":"Tretinoin: A review of its anti\u2010inflammatory properties in the treatment of acne","volume":"4","author":"Schmidt N","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2467"},{"key":"e_1_2_8_35_1","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double\u2010blind, randomized, vehicle\u2010controlled study","volume":"77","author":"Grimes P","year":"2006","journal-title":"Cutis"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x"},{"key":"e_1_2_8_37_1","first-page":"405","article-title":"Clindamycin phosphate 1.2%\u2010 tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability","volume":"81","author":"Del Rosso JQ","year":"2008","journal-title":"Cutis"},{"key":"e_1_2_8_38_1","first-page":"27","article-title":"Microsphere technology: hype or help?","volume":"4","author":"Kircik LH","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1969.01610220097017"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2008.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464210-00002"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04276.x"},{"key":"e_1_2_8_43_1","first-page":"15","article-title":"A review of the anti\u2010inflammatory properties of clindamycin in the treatment of acne vulgaris","volume":"85","author":"Del Rosso JQ","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2309"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05067.x"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04270.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3004.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/000155502320323216"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06614.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903277228"},{"key":"e_1_2_8_51_1","first-page":"103","article-title":"Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial","volume":"86","author":"Yentzer BA","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.34010"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_8_54_1","unstructured":"Duac.Summary of product characteristics.Stiefel (a GlaxoSmithKline Company) UK 2011."}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13186","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13186","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T08:09:07Z","timestamp":1694592547000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":53,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/jdv.13186"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13186","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}